Company Search:
Advanced Search
Sponsored Links
Botanix Pharmaceuticals Ltd Company Snapshot
Botanix Pharmaceuticals Ltd operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Botanix Pharmaceuticals Ltd with three other companies in this sector in Australia: Innate Immunotherapeutics Ltd (2015 sales of 30,309.00 Australian Dollars [US$23,066.36 ] ), Actinogen Medical Ltd (49,927.00 Australian Dollars [US$37,996.44 ] ), and Ephraim Resources Ltd (29,079.00 Australian Dollars [US$22,130.28 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Botanix Pharmaceuticals Ltd
  Stock Performance Chart for Botanix Pharmaceuticals Ltd
  Stock Data: Recent Stock Performance:
  Current Price (10/21/2016): .05
(Figures in Australian Dollars)
1 Week 4.3%   13 Weeks 37.1%  
4 Weeks -9.4%   52 Weeks 105.7%  
Botanix Pharmaceuticals Ltd Key Data:
  Ticker: BOT Country: Australia
  Exchanges: Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 43,090
(Year Ending Jan 2016).
Employees: 1
  Currency: Australian Dollars Market Cap: 18,653,679
  Fiscal Yr Ends: June Shares Outstanding: 405,514,770
  Share Type: Ordinary Closely Held Shares: 249,678,522
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.